Vincent Haufroid

14PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersAutonomic nervous systemGene and molecular therapySub-acute carePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 04, 2025
Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.

Julien De Greef, Jean Cyr Yombi, Anne Vincent

|Nov 25, 2024
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.

Louis Lebreton, Jean-Christophe Boyer, Claire Lafay-Chebassier

|Mar 04, 2024
Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury.

Elise André, Florian Lemaitre, Marie-Clémence Verdier

|Oct 17, 2023
Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross-Sectional Study.

Alexandra L Degraeve, Laure B Bindels, Vincent Haufroid

|Jul 05, 2023
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1.

Alexandra L Degraeve, Vincent Haufroid, Axelle Loriot

Pageof 3